Important note: Information in this article was accurate in October 2003. The state of the art may have changed since the publication date.
 |
HIV Treatment Bulletin - October 2003
Polly Clayden HIV i-Base
The MTCT-Plus initiative provides HIV care including antiretrovirals to HIV-positive women identified during pregnancy, and their families. This project was launched in 2001 as a response to Kofi Annan’s “Call to Action”. It utilises antenatal care as an entry point to HIV treatment and acknowledges that MTCT programmes in resource poor settings have generated cohorts of HIV-positive women without access to treatment for their own health.
Representatives from MTCT-Plus, including principal investigator Wafaa El-Sadr, provided an overview of the project since enrollment started in February of this year. Sites have now been established in Cote D’Ivoire, Kenya, Mozambique, Rwanda, South Africa, Thailand, Uganda and Zambia and a multidisciplinary “essential package” has been developed that is family focused and includes both clinical and psychosocial services, including adherence support, for adults and children.
Training of healthcare teams has been conducted and a central procurement system established for medications, including antiretrovirals, and supplies through UNICEF. Medications, including generics, on the WHO pre-qualified list are used. They have developed a system of data collection and programme evaluation that includes sharing information between sites to assist in programme development.
As of 30 May, 574 patients have been enrolled at seven MTCT-Plus programme sites including 405 adults and 169 children.
In a completely uplifting presentation, Dr Sylvester Kimaio from Eldoret, Kenya described his experiences. So far, 240 adults and 90 children have been enrolled into Eldoret’s programme.
Recently they have begun initiating HAART in the second trimester for their pregnant patients and unsurprisingly the transmission rate in his cohort has gone into freefall. “In the west they don’t use nevirapine for MTCT they use full HAART,” he explained. “We thought: ‘Why not us?’ We have already started that programme so we will be very successful with our PMTCT.” In fact, he continued: “We are hoping that our PMTCT is so successful that we can take some of the spaces for the children and give them to the mothers.”
He concluded his talk with a picture of one of his patients: “She has five children… we don’t have to look after orphans… she looks after them herself.”
Ref: El-Sadr W, Kimaio S, Hardy T et al. The MTCT-Plus initiative: A model for comprehensive family-focused HIV care and treatment in resource limited settings
Links
E-mail:mtctplus@columbia.edu
031010
IB30408-13
©2003. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
